BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax.
Following a period of sustained growth, with revenues increasing from £4m to £12m during BGF’s investment, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH in November 2015 with all shareholders realising a strong return.
Business funding insights
How to grow your company through acquisition
Gurinder Sunner, head of BGF in the Midlands considers ‘How to grow your company through acquisition’ In its simplest form,…
Infrastructure spending is only one part of the solution
The chancellor is right to back an investment-led recovery, but infrastructure is only part of the solution. Business funding is needed too.